Wim Jiskoot spends much of his time researching Immunogenicity, Immunology, Immune system, Antigen and Antibody. His Immunogenicity research includes themes of Molecular biology, Computational biology, Drug delivery and Virology. His Immunology course of study focuses on PLGA and Drug carrier and CD8.
His studies deal with areas such as Chitosan and Adjuvant as well as Antigen. His Antibody research is multidisciplinary, relying on both Protein structure and Protein aggregation. His biological study spans a wide range of topics, including Pharmacology toxicology, Biophysics, Chromatography and Dynamic light scattering.
His scientific interests lie mostly in Immunogenicity, Chromatography, Immunology, Antigen and Immune system. His Immunogenicity study integrates concerns from other disciplines, such as Chitosan, Molecular biology, Protein aggregation and Virology. His study in Chitosan is interdisciplinary in nature, drawing from both Dextran, Microparticle and Nasal administration.
In Protein aggregation, Wim Jiskoot works on issues like Biophysics, which are connected to Fluorescence spectroscopy and Peptide. His Chromatography research is multidisciplinary, incorporating perspectives in Toxoid, Circular dichroism, Monoclonal antibody and Supercritical fluid. In his study, which falls under the umbrella issue of Antigen, Liposome and Cationic liposome is strongly linked to Adjuvant.
Wim Jiskoot mainly focuses on Immunogenicity, Antigen, Liposome, Biophysics and Adjuvant. Wim Jiskoot has researched Immunogenicity in several fields, including Protein aggregation, Monoclonal antibody and Peptide. Wim Jiskoot studied Protein aggregation and Antibody that intersect with In vitro.
His study in the field of Ovalbumin and Toxoid also crosses realms of Human skin. His Biophysics study combines topics from a wide range of disciplines, such as Nanoparticle and In vivo. His research integrates issues of Molecular biology, Immunization and Virology in his study of Adjuvant.
Wim Jiskoot focuses on Immunogenicity, Ex vivo, Nanoparticle, Liposome and Antigen. The various areas that Wim Jiskoot examines in his Immunogenicity study include Biophysics, Protein aggregation and Particle size. His research in Ex vivo intersects with topics in Antibody and Monoclonal.
His Liposome research is multidisciplinary, relying on both Cationic liposome and Zeta potential. As a member of one scientific family, Wim Jiskoot mostly works in the field of Cationic liposome, focusing on Immunology and, on occasion, Microbiology. He combines subjects such as Adjuvant and PLGA with his study of Antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates
Vasco Filipe;Vasco Filipe;Andrea Hawe;Wim Jiskoot.
Pharmaceutical Research (2010)
Extrinsic fluorescent dyes as tools for protein characterization.
Andrea Hawe;Marc Sutter;Marc Sutter;Wim Jiskoot.
Pharmaceutical Research (2008)
Protein instability in poly(lactic-co-glycolic acid) microparticles.
Marco van de Weert;Wim E. Hennink;Wim Jiskoot.
Pharmaceutical Research (2000)
Structure-immunogenicity relationships of therapeutic proteins.
Suzanne Hermeling;Daan J. A. Crommelin;Huub Schellekens;Wim Jiskoot.
Pharmaceutical Research (2004)
Identification of Formaldehyde-induced Modifications in Proteins REACTIONS WITH MODEL PEPTIDES
Bernard Metz;Gideon F.A. Kersten;Peter Hoogerhout;Humphrey F. Brugghe.
Journal of Biological Chemistry (2004)
Chitosan-based delivery systems for protein therapeutics and antigens
Maryam Amidi;Enrico Mastrobattista;Wim Jiskoot;Wim E. Hennink.
Advanced Drug Delivery Reviews (2010)
Overlooking subvisible particles in therapeutic protein products: Gaps that may compromise product quality
John F. Carpenter;Theodore W. Randolph;Wim Jiskoot;Daan J.A. Crommelin.
Journal of Pharmaceutical Sciences (2009)
Microneedle technologies for (trans)dermal drug and vaccine delivery.
Koen van der Maaden;Wim Jiskoot;Joke Bouwstra.
Journal of Controlled Release (2012)
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Maryam Amidi;Stefan G. Romeijn;Gerrit Borchard;Hans E. Junginger.
Journal of Controlled Release (2006)
ESAT-6 from Mycobacterium tuberculosis Dissociates from Its Putative Chaperone CFP-10 under Acidic Conditions and Exhibits Membrane-Lysing Activity
Marien I. de Jonge;Gérard Pehau-Arnaudet;Marjan M. Fretz;Felix Romain.
Journal of Bacteriology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: